Beware of fraudulent COVID-19 tests, vaccines and treatments
While we remain vigilant to protect our families and communities from COVID-19, some people might be tempted to buy or use questionable products that...
Pfizer, Moderna, and Johnson & Johnson COVID vaccines: Which elicits the strongest immune responses?
The U.S. Food & Drug Administration granted emergency use authorization to the mRNA-based vaccines known as BNT162b2 (BioNTech, Pfizer) and mRNA-1273 (Moderna) in December...
One coronavirus vaccine may protect against other coronaviruses
In a new study from Northwestern Medicine, researchers found that coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses.
The...
High-dose of this blood thinner can reduce death risk in COVID-19
In a new study from St. Michael's Hospital, researchers found a high dose of an inexpensive and globally available blood-thinning medication reduces the risk...
How many people get ‘long COVID?’ More than half, study finds
In a new study from Penn State, researchers found more than half of the 236 million people who have been diagnosed with COVID-19 worldwide...
Cholesterol-lowering drugs linked to lower death in COVID-19
Statins are a recommended and common intervention for preventing cardiovascular events by reducing levels of lipoprotein cholesterol in the blood.
During the pandemic, it has...
This drug combo may help cure COVID-19
In a recent study, researchers discovered a drug combo that may cure COVID-19 together.
The study is from the Tokyo University of Science. The finding...
This number linked to death and longer ICU stay for COVID patients
In a new study from the University of Gothenburg, researchers found in patients with COVID-19, a high body mass index (BMI) is associated with...
The differences and similarities between the flu and COVID-19
The viruses that cause the flu and COVID-19 are not the same, and the diseases are different, too. But they have a lot in...
What is long COVID?
In fall 2020, clinicians at Emory began treating a growing group of patients who had seemingly recovered from acute COVID-19 illness, but still suffered...